{"id":"https://openalex.org/W3191898951","doi":"https://doi.org/10.1111/bjh.17730","title":"Fimepinostat (CUDC\u2010907) in patients with relapsed/refractory diffuse large B cell and high\u2010grade B\u2010cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses","display_name":"Fimepinostat (CUDC\u2010907) in patients with relapsed/refractory diffuse large B cell and high\u2010grade B\u2010cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses","publication_year":2021,"publication_date":"2021-08-02","ids":{"openalex":"https://openalex.org/W3191898951","doi":"https://doi.org/10.1111/bjh.17730","mag":"3191898951","pmid":"https://pubmed.ncbi.nlm.nih.gov/34341990"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.17730","doi":"https://doi.org/10.1111/bjh.17730","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.17730","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.17730","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.17730","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042844727","display_name":"Daniel Jeffrey Landsburg","orcid":"https://orcid.org/0000-0002-5077-4181","observed_orcids":["https://orcid.org/0000-0002-5077-4181"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel J. Landsburg","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":"https://orcid.org/0000-0002-5077-4181","affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019666650","display_name":"Stefan Klaus Barta","orcid":"https://orcid.org/0000-0002-3280-5271","observed_orcids":["https://orcid.org/0000-0002-3280-5271"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefan K. Barta","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA, USA","University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052962596","display_name":"Radhakrishnan Ramchandren","orcid":"https://orcid.org/0000-0002-5969-3337","observed_orcids":["https://orcid.org/0000-0002-5969-3337"]},"institutions":[{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]},{"id":"https://openalex.org/I75027704","display_name":"University of Tennessee at Knoxville","ror":"https://ror.org/020f3ap87","country_code":"US","type":"education","lineage":["https://openalex.org/I75027704"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Radhakrishnan Ramchandren","raw_affiliation_strings":["Karmanos Cancer Institute, Detroit, MI, USA","University of Tennessee Knoxville, Knoxville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karmanos Cancer Institute, Detroit, MI, USA","institution_ids":["https://openalex.org/I4210090317"]},{"raw_affiliation_string":"University of Tennessee Knoxville, Knoxville, TN, USA","institution_ids":["https://openalex.org/I75027704"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045676616","display_name":"Connie Lee Batlevi","orcid":"https://orcid.org/0000-0002-9036-9463","observed_orcids":["https://orcid.org/0000-0002-9036-9463"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Connie Batlevi","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027071793","display_name":"Swaminathan P. Iyer","orcid":"https://orcid.org/0000-0002-1646-813X","observed_orcids":["https://orcid.org/0000-0002-1646-813X"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Swaminathan Iyer","raw_affiliation_strings":["Houston Methodist Hospital, Houston, TX, USA","MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Houston Methodist Hospital, Houston, TX, USA","institution_ids":["https://openalex.org/I1295876152"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005922094","display_name":"Kevin R. Kelly","orcid":"https://orcid.org/0000-0002-3638-5956","observed_orcids":["https://orcid.org/0000-0002-3638-5956"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Kelly","raw_affiliation_strings":["University of Southern California, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048644166","display_name":"Ivana N. Micallef","orcid":"https://orcid.org/0000-0002-4675-4903","observed_orcids":["https://orcid.org/0000-0002-4675-4903"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivana N. Micallef","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005159945","display_name":"Sonali M. Smith","orcid":"https://orcid.org/0000-0002-9893-4949","observed_orcids":["https://orcid.org/0000-0002-9893-4949"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonali M. Smith","raw_affiliation_strings":["University of Chicago, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030896087","display_name":"Don Ambrose Stevens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202709704","display_name":"Norton Healthcare","ror":"https://ror.org/0266h1q26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Don A. Stevens","raw_affiliation_strings":["Norton Cancer Institute, Louisville, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norton Cancer Institute, Louisville, KY, USA","institution_ids":["https://openalex.org/I202709704"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017756904","display_name":"Mariano J. Alvarez","orcid":"https://orcid.org/0000-0002-7503-2491","observed_orcids":["https://orcid.org/0000-0002-7503-2491"]},"institutions":[{"id":"https://openalex.org/I4210146950","display_name":"DarwinHealth (United States)","ror":"https://ror.org/04t9aj866","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariano Alvarez","raw_affiliation_strings":["DarwinHealth, Inc, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DarwinHealth, Inc, New York, NY, USA","institution_ids":["https://openalex.org/I4210146950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046245448","display_name":"Andrea Califano","orcid":"https://orcid.org/0000-0003-4742-3679","observed_orcids":["https://orcid.org/0000-0003-4742-3679"]},"institutions":[{"id":"https://openalex.org/I4210146950","display_name":"DarwinHealth (United States)","ror":"https://ror.org/04t9aj866","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Califano","raw_affiliation_strings":["DarwinHealth, Inc, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DarwinHealth, Inc, New York, NY, USA","institution_ids":["https://openalex.org/I4210146950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101495229","display_name":"Yao Shen","orcid":"https://orcid.org/0000-0002-6847-2691","observed_orcids":["https://orcid.org/0000-0002-6847-2691","https://orcid.org/0000-0002-4472-9632","https://orcid.org/0009-0008-4277-4406"]},"institutions":[{"id":"https://openalex.org/I4210146950","display_name":"DarwinHealth (United States)","ror":"https://ror.org/04t9aj866","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yao Shen","raw_affiliation_strings":["DarwinHealth, Inc, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DarwinHealth, Inc, New York, NY, USA","institution_ids":["https://openalex.org/I4210146950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021268001","display_name":"Gideon Bosker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146950","display_name":"DarwinHealth (United States)","ror":"https://ror.org/04t9aj866","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gideon Bosker","raw_affiliation_strings":["DarwinHealth, Inc, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DarwinHealth, Inc, New York, NY, USA","institution_ids":["https://openalex.org/I4210146950"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jefferson Parker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130089","display_name":"Curis (United States)","ror":"https://ror.org/02g6ngv74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130089"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jefferson Parker","raw_affiliation_strings":["Curis, Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curis, Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I4210130089"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067448328","display_name":"Raul Soikes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130089","display_name":"Curis (United States)","ror":"https://ror.org/02g6ngv74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130089"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raul Soikes","raw_affiliation_strings":["Curis, Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curis, Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I4210130089"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045049807","display_name":"Elizabeth M. Martinez","orcid":"https://orcid.org/0000-0001-6592-347X","observed_orcids":["https://orcid.org/0000-0001-6592-347X"]},"institutions":[{"id":"https://openalex.org/I4210130089","display_name":"Curis (United States)","ror":"https://ror.org/02g6ngv74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130089"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Martinez","raw_affiliation_strings":["Curis, Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curis, Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I4210130089"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013979917","display_name":"Reinhard von Roemeling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130089","display_name":"Curis (United States)","ror":"https://ror.org/02g6ngv74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130089"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reinhard von Roemeling","raw_affiliation_strings":["Curis, Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curis, Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I4210130089"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007507499","display_name":"Robert E. Martell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130089","display_name":"Curis (United States)","ror":"https://ror.org/02g6ngv74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130089"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert E. Martell","raw_affiliation_strings":["Curis, Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Curis, Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I4210130089"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037784199","display_name":"Yasuhiro Oki","orcid":"https://orcid.org/0000-0003-3038-4298","observed_orcids":["https://orcid.org/0000-0003-3038-4298"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yasuhiro Oki","raw_affiliation_strings":["Genentech, San Francisco, CA, USA","MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5042844727"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":6.7799,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.9767504,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"195","issue":"2","first_page":"201","last_page":"209"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cudc-907","display_name":"CUDC-907","score":0.9990000128746033},{"id":"https://openalex.org/keywords/relapsed-refractory-diffuse-large-b-cell-lymphoma","display_name":"relapsed/refractory diffuse large B-cell lymphoma","score":0.875},{"id":"https://openalex.org/keywords/high-grade-b-cell-lymphoma","display_name":"high-grade B-cell lymphoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8970000147819519},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.9610000252723694},{"id":"https://openalex.org/keywords/myc-protein-expression","display_name":"MYC protein expression","score":0.9290000200271606},{"id":"https://openalex.org/keywords/myc-rearrangement","display_name":"MYC rearrangement","score":0.8930000066757202},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.796999990940094},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.9120000004768372},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.737109363079071},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6060811877250671},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5848997235298157},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5545437335968018},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5435582995414734},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5269306898117065},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5109678506851196},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4527280330657959},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4200289249420166},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.41591253876686096},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37666767835617065},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3737142086029053},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25167375802993774},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D016271","descriptor_name":"Proto-Oncogene Proteins c-myc","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/bjh.17730","doi":"https://doi.org/10.1111/bjh.17730","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.17730","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.17730","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:34341990","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34341990","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1111/bjh.17730","doi":"https://doi.org/10.1111/bjh.17730","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.17730","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.17730","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8058929040","display_name":"Systematic Identification and Pharmacological Targeting of Tumor Dependencies for Precision Cancer Medicine","funder_award_id":"U01CA217858","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000902828","display_name":"Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level","funder_award_id":"R35CA197745","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3191898951.pdf","grobid_xml":"https://content.openalex.org/works/W3191898951.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1554663460","https://openalex.org/W1965254413","https://openalex.org/W1988817337","https://openalex.org/W2029473952","https://openalex.org/W2057239580","https://openalex.org/W2062348957","https://openalex.org/W2103017472","https://openalex.org/W2105031411","https://openalex.org/W2116956926","https://openalex.org/W2133201432","https://openalex.org/W2137216850","https://openalex.org/W2155953052","https://openalex.org/W2156892326","https://openalex.org/W2158267770","https://openalex.org/W2161409973","https://openalex.org/W2300908044","https://openalex.org/W2301934011","https://openalex.org/W2317505970","https://openalex.org/W2472255748","https://openalex.org/W2484616545","https://openalex.org/W2561238268","https://openalex.org/W2609884290","https://openalex.org/W2752305310","https://openalex.org/W2775670706","https://openalex.org/W2887063854","https://openalex.org/W2891146926","https://openalex.org/W2950676576","https://openalex.org/W2969931905","https://openalex.org/W3005797416","https://openalex.org/W3048543001","https://openalex.org/W3095072946","https://openalex.org/W3175087377","https://openalex.org/W4388297464","https://openalex.org/W6641557765"],"related_works":["https://openalex.org/W2917574729","https://openalex.org/W2889420503","https://openalex.org/W2984900646","https://openalex.org/W3030924468","https://openalex.org/W3030001517","https://openalex.org/W2752305310","https://openalex.org/W2588820872","https://openalex.org/W2533216488","https://openalex.org/W2950214597","https://openalex.org/W2890136077"],"abstract_inverted_index":{"Fimepinostat":[0],"(CUDC-907),":[1],"a":[2,16,48,110,156],"first-in-class":[3],"oral":[4],"small-molecule":[5],"inhibitor":[6],"of":[7,20,52,68,104,116,166,170],"histone":[8],"deacetylase":[9],"and":[10,27,97,153,162],"phosphatidylinositol":[11],"3-kinase,":[12],"demonstrated":[13],"efficacy":[14],"in":[15,56,197],"phase":[17,49,95],"1":[18,96],"study":[19,51],"patients":[21,63,74,90,126,143,175],"with":[22,34,60,75,127,140,160,176,181],"relapsed/refractory":[23],"(R/R)":[24],"diffuse":[25],"large":[26],"high-grade":[28],"B-cell":[29],"lymphomas":[30],"(DLBCL/HGBL),":[31],"particularly":[32],"those":[33],"increased":[35],"MYC":[36,40],"protein":[37],"expression":[38],"and/or":[39,186],"gene":[41],"rearrangement/copy":[42],"number":[43],"gain":[44],"(MYC-altered":[45],"disease).":[46],"Therefore,":[47],"2":[50,98],"fimepinostat":[53],"was":[54,81,138],"conducted":[55],"this":[57],"patient":[58,188],"population":[59],"66":[61],"eligible":[62],"treated.":[64],"The":[65],"primary":[66],"end-point":[67],"overall":[69,134],"response":[70,135,171,195],"(OR)":[71,136],"rate":[72,137],"for":[73,147],"MYC-IHC":[76],"\u226540%":[77],"(n":[78,130],"=":[79,131],"46)":[80],"15%.":[82],"Subsequently,":[83],"exploratory":[84],"pooled":[85],"analyses":[86],"were":[87,172],"performed":[88],"including":[89],"treated":[91,180],"on":[92,145],"both":[93],"the":[94,102,133],"studies":[99],"based":[100],"upon":[101],"presence":[103],"MYC-altered":[105,128,177],"disease":[106,129],"as":[107,109],"well":[108],"biomarker":[111,158],"identified":[112],"by":[113,119,174],"Virtual":[114],"Inference":[115],"Protein":[117],"activity":[118],"Enriched":[120],"Regulon":[121],"analysis":[122],"(VIPER).":[123],"For":[124],"these":[125],"63),":[132],"22%":[139],"seven":[141],"responding":[142],"remaining":[144],"treatment":[146],"approximately":[148],"two":[149],"years":[150],"or":[151],"longer,":[152],"VIPER":[154],"yielded":[155],"three-protein":[157],"classification":[159],"positive":[161],"negative":[163],"predictive":[164],"values":[165],"\u226585%.":[167],"Prolonged":[168],"durations":[169],"achieved":[173],"R/R":[178],"DLBCL/HGBL":[179],"single-agent":[182],"fimepinostat.":[183],"Combination":[184],"therapies":[185],"biomarker-based":[187],"selection":[189],"strategies":[190],"may":[191],"lead":[192],"to":[193],"higher":[194],"rates":[196],"future":[198],"clinical":[199],"trials.":[200]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-08-16T00:00:00"}